What is OMCL revenue?

Omnicell Inc. (OMCL) reported $1.24B of revenue for the twelve months ended Sep 30, 2026. That is up 5.6% from the year before. Revenue for fiscal 2025 was $1.18B.

Yes. Omnicell Inc. earned $44.66M in net income for the twelve months ended Sep 30, 2026, a net margin of 3.6%.

How much cash and debt does OMCL have?

Omnicell Inc. reported $314.86M in cash and cash equivalents and $168.51M of debt on its most recent balance sheet in SEC filings.

How fast is OMCL revenue growing?

Omnicell Inc.'s revenue changed +6.5% in fiscal 2025, to $1.18B. Its compound annual growth rate was +5.8% over 5 years and +9.4% over 10 years.

What is OMCL gross margin?

Omnicell Inc.'s gross profit was $561.45M on $1.24B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 45.1%.

What is OMCL free cash flow?

Omnicell Inc. generated $145.77M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $186.22M less capital expenditures.

What is OMCL earnings per share?

Diluted earnings per share were $0.96 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did OMCL last report financial results?

The latest statements here come from Omnicell Inc.'s 10-Q filed on Nov 4, 2026, covering the period ended Sep 30, 2026.

Where does this OMCL financial data come from?

Quantisnow builds these statements from the structured XBRL data Omnicell Inc. files with the SEC. It is provided for information only and is not investment advice.

Financials · OMCL

Omnicell Inc. (OMCL) financials

For the twelve months ended Sep 30, 2026, Omnicell Inc. reported $1.24B of revenue and $44.66M of net income.

Revenue, TTM: $1.24B
Revenue growth, YoY: +5.6%
Net income, TTM: $44.66M
Net income growth, YoY: +124.2%
Net margin: 3.6%
Free cash flow, TTM: $145.77M
EPS, diluted, TTM: $0.96
EPS growth, YoY: +123.3%
Cash: $314.86M
Total debt: $168.51M
P/E: 38.45
P/S: 1.38
Market cap: $1.72B

Annual revenue$1.18B

FY2016FY2025

Annual net income$2.05M

FY2016FY2025

Annual free cash flow$86.89M

FY2016FY2025

OMCL revenue and earnings growth

OMCL revenueQ3 2026$307.85M

Quarter YoY: -0.9%
QoQ: -1.4%
FY YoY: +6.5%
5Y CAGR: +5.8%
10Y CAGR: +9.4%

OMCL revenue was $307.85M in fiscal Q3 2026 (ended Sep 30, 2026), down 0.9% from a year earlier and down 1.4% from the prior quarter. For the full fiscal 2025 it was $1.18B, up 6.5% from fiscal 2024. Compound annual growth was +5.8% over 5 years and +9.4% over 10 years. It rose in 7 of the last 10 fiscal years.

OMCL net incomeQ3 2026$11.04M

Quarter YoY: +102.2%
QoQ: -54.5%
FY YoY: -83.6%
5Y CAGR: -42.3%
10Y CAGR: -23.7%

OMCL net income was $11.04M in fiscal Q3 2026 (ended Sep 30, 2026), up 102.2% from a year earlier and down 54.5% from the prior quarter. For the full fiscal 2025 it was $2.05M, down 83.6% from fiscal 2024. Compound annual growth was -42.3% over 5 years and -23.7% over 10 years.

OMCL EPSQ3 2026$0.24

Quarter YoY: +100.0%
QoQ: -53.8%
FY YoY: -85.2%
5Y CAGR: -44.2%
10Y CAGR: -26.2%

OMCL diluted EPS was $0.24 in fiscal Q3 2026 (ended Sep 30, 2026), up 100.0% from a year earlier and down 53.8% from the prior quarter. For the full fiscal 2025 it was $0.04, down 85.2% from fiscal 2024. Compound annual growth was -44.2% over 5 years and -26.2% over 10 years.

OMCL free cash flowQ3 2026$21.69M

Quarter YoY: +17.1%
QoQ: -63.5%
FY YoY: -42.6%
5Y CAGR: -11.8%
10Y CAGR: +10.9%

OMCL free cash flow was $21.69M in fiscal Q3 2026 (ended Sep 30, 2026), up 17.1% from a year earlier and down 63.5% from the prior quarter. For the full fiscal 2025 it was $86.89M, down 42.6% from fiscal 2024. Compound annual growth was -11.8% over 5 years and +10.9% over 10 years. It rose in 7 of the last 10 fiscal years.

Export CSV

Income statement

Income statement
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue	$1.18B	$1.11B	$1.15B	$1.30B	$1.13B	$892.21M	$897.03M	$787.31M	$712.71M	$695.91M
Cost of revenue	$681.40M	$641.24M	$650.27M	$706.96M	$577.37M	$478.92M	$460.12M	$414.98M	$394.08M	$378.82M
Gross profit	$503.44M	$471.00M	$496.84M	$588.99M	$554.65M	$413.29M	$436.91M	$372.33M	$318.64M	$317.08M
Research and development	$88.67M	$90.41M	$97.11M	$104.97M	$75.72M	$70.16M	$68.64M	$64.84M	$66.02M	$57.80M
Selling, general and admin	$409.61M	$380.25M	$434.59M	$486.34M	$389.43M	$307.61M	$289.92M	$263.10M	$241.47M	$237.88M
Operating income	$5.16M	$337.0K	-$34.87M	-$2.32M	$89.51M	$35.53M	$78.35M	$44.39M	$11.14M	$21.41M
Pre-tax income	$11.32M	$25.59M	-$20.11M	-$2.45M	$66.01M	$29.35M	$73.93M	$35.62M	$4.51M	$12.98M
Income tax	$9.27M	$13.06M	$263.0K	-$8.10M	-$11.84M	-$2.85M	$12.60M	-$2.11M	-$26.01M	$3.22M
Net income	$2.05M	$12.53M	-$20.37M	$5.65M	$77.85M	$32.19M	$61.34M	$37.73M	$30.52M	$9.76M
EPS, basic	$0.04	$0.27	-$0.45	$0.13	$1.79	$0.76	$1.48	$0.96	$0.81	$0.27
EPS, diluted	$0.04	$0.27	-$0.45	$0.12	$1.62	$0.74	$1.43	$0.93	$0.79	$0.26
Diluted shares	46.4M	46.3M	45.2M	45.9M	47.9M	43.7M	42.9M	40.6M	38.7M	36.9M

Balance sheet

Balance sheet
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Cash and equivalents	$196.52M	$398.61M	$467.97M	$352.83M	$355.62M	$489.92M	$127.21M	$67.19M	$32.42M	$54.49M
Receivables	$216.86M	$256.40M	$252.03M	$299.47M	$240.89M	$190.12M	$218.36M	$196.24M	$190.05M	$150.30M
Inventory	$100.91M	$88.66M	$110.10M	$147.55M	$119.92M	$96.30M	$108.01M	$100.87M	$96.14M	$69.30M
Current assets	$680.07M	$815.49M	$927.57M	$881.81M	$780.70M	$829.41M	$483.24M	$397.13M	$352.27M	$315.41M
Goodwill	$737.95M	$734.73M	$735.81M	$734.27M	$738.90M	$499.31M	$336.54M	$335.89M	$337.75M	$327.72M
Total assets	$1.97B	$2.12B	$2.23B	$2.21B	$2.14B	$1.82B	$1.24B	$1.08B	$1.02B	$935.10M
Current liabilities	$476.61M	$595.68M	$367.79M	$428.45M	$876.16M	$276.42M	$237.00M	$204.58M	$205.21M	$180.91M
Short-term debt	-	-	-	-	-	-	-	$0	$15.21M	$8.41M
Long-term debt	$167.60M	$166.40M	$569.66M	$566.57M	$0	$467.20M	$0	$135.42M	$194.92M	$245.73M
Total debt	$167.60M	$166.40M	$569.66M	$566.57M	$0	$467.20M	$0	$135.42M	$210.13M	$254.14M
Total liabilities	$742.91M	$877.65M	$1.04B	$1.08B	$995.81M	$857.00M	$395.56M	$401.63M	$462.02M	$503.50M
Shareholders' equity	$1.23B	$1.24B	$1.19B	$1.13B	$1.15B	$967.50M	$845.25M	$679.62M	$554.34M	$458.84M

Cash flow

Cash flow
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Operating cash flow	$127.30M	$187.72M	$181.09M	$77.78M	$231.81M	$185.87M	$145.01M	$103.97M	$24.83M	$49.90M
Capital expenditures	$40.41M	$36.46M	$41.47M	$47.54M	$28.97M	$22.84M	$15.89M	$23.70M	$15.34M	$13.45M
Free cash flow	$86.89M	$151.26M	$139.62M	$30.25M	$202.84M	$163.03M	$129.11M	$80.27M	$9.49M	$36.45M
Investing cash flow	-$60.36M	-$52.79M	-$55.02M	-$58.67M	-$412.50M	-$279.87M	-$61.66M	-$54.37M	-$34.99M	-$341.32M
Financing cash flow	-$218.32M	-$235.58M	$23.42M	-$20.95M	$47.36M	$456.27M	-$23.48M	-$13.60M	-$9.88M	$263.75M
Share repurchases	$77.60M	$0	$0	$52.21M	$0	$53.03M	$0	$0	$0	$0
Stock-based compensation	$44.50M	$39.32M	$55.30M	$68.25M	$53.16M	$44.70M	$34.05M	$28.89M	$21.86M	$19.50M
Depreciation and amortization	$78.80M	$82.23M	$87.32M	$86.93M	$72.99M	$61.07M	$53.56M	$51.35M	$51.51M	$58.36M

Key ratios

Key ratios
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue growth, YoY	6.5%	-3.0%	-11.5%	14.5%	26.9%	-0.5%	13.9%	10.5%	2.4%	43.6%
Net income growth, YoY	-83.6%	-	-	-92.7%	141.8%	-47.5%	62.6%	23.6%	212.8%	-68.3%
EPS growth, YoY	-85.2%	-	-	-92.6%	118.9%	-48.3%	53.8%	17.7%	203.8%	-69.0%
Gross margin	42.5%	42.3%	43.3%	45.4%	49.0%	46.3%	48.7%	47.3%	44.7%	45.6%
Operating margin	0.4%	0.0%	-3.0%	-0.2%	7.9%	4.0%	8.7%	5.6%	1.6%	3.1%
Net margin	0.2%	1.1%	-1.8%	0.4%	6.9%	3.6%	6.8%	4.8%	4.3%	1.4%
Free cash flow margin	7.3%	13.6%	12.2%	2.3%	17.9%	18.3%	14.4%	10.2%	1.3%	5.2%
Return on equity	0.2%	1.0%	-1.7%	0.5%	6.8%	3.3%	7.3%	5.6%	5.5%	2.1%
Return on assets	0.1%	0.6%	-0.9%	0.3%	3.6%	1.8%	4.9%	3.5%	3.0%	1.0%
Current ratio	1.43	1.37	2.52	2.06	0.89	3.00	2.04	1.94	1.72	1.74
Debt to equity	0.14	0.13	0.48	0.50	0.00	0.48	0.00	0.20	0.38	0.55

Income statement

Income statement
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue	$307.85M	$312.21M	$309.88M	$313.98M	$310.63M	$290.56M	$269.67M	$306.88M	$282.42M	$276.79M	$246.15M	$258.85M
Cost of revenue	$170.03M	$159.27M	$169.52M	$183.66M	$176.13M	$162.88M	$158.73M	$165.12M	$160.15M	$162.44M	$153.53M	$153.44M
Gross profit	$137.83M	$152.94M	$140.36M	$130.32M	$134.50M	$127.68M	$110.94M	$141.76M	$122.27M	$114.35M	$92.62M	$105.40M
Research and development	$22.35M	$20.30M	$21.52M	$22.55M	$24.02M	$21.57M	$20.53M	$26.04M	$21.21M	$21.10M	$22.06M	$26.82M
Selling, general and admin	$100.54M	$100.19M	$101.99M	$107.36M	$102.24M	$97.98M	$102.03M	$103.33M	$94.49M	$90.03M	$92.41M	$101.95M
Operating income	$14.93M	$32.45M	$16.85M	$415.0K	$8.24M	$8.12M	-$11.62M	$12.40M	$6.56M	$3.22M	-$21.85M	-$23.36M
Pre-tax income	$15.80M	$33.83M	$16.91M	$699.0K	$9.70M	$10.45M	-$9.53M	$23.60M	$11.63M	$8.20M	-$17.83M	-$18.52M
Income tax	$4.76M	$9.54M	$5.55M	$2.73M	$4.24M	$4.81M	-$2.51M	$7.76M	$3.00M	$4.46M	-$2.15M	-$4.14M
Net income	$11.04M	$24.29M	$11.36M	-$2.03M	$5.46M	$5.64M	-$7.02M	$15.84M	$8.63M	$3.73M	-$15.68M	-$14.38M
EPS, basic	$0.24	$0.53	$0.25	-$0.05	$0.12	$0.12	-$0.15	$0.34	$0.19	$0.08	-$0.34	-$0.32
EPS, diluted	$0.24	$0.52	$0.25	-$0.05	$0.12	$0.12	-$0.15	$0.34	$0.19	$0.08	-$0.34	-$0.32
Diluted shares	46.5M	46.3M	45.9M	-	45.9M	47.0M	46.6M	-	46.4M	46.0M	45.7M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Cash and equivalents	$314.86M	$292.17M	$239.22M	$196.52M	$180.05M	$399.00M	$386.83M	$398.61M	$570.63M	$556.78M	$512.36M	$467.97M
Receivables	$236.05M	$227.05M	$249.80M	$216.86M	$245.72M	$232.68M	$251.60M	$256.40M	$251.76M	$241.13M	$248.51M	$252.03M
Inventory	$98.28M	$96.72M	$99.20M	$100.91M	$107.43M	$105.78M	$91.14M	$88.66M	$95.06M	$93.26M	$103.47M	$110.10M
Current assets	$783.98M	$735.39M	$722.30M	$680.07M	$659.62M	$844.78M	$839.67M	$815.49M	$1.01B	$995.67M	$989.92M	$927.57M
Goodwill	$737.13M	$737.20M	$737.29M	$737.95M	$737.87M	$738.49M	$735.96M	$734.73M	$737.17M	$735.35M	$735.36M	$735.81M
Total assets	$2.06B	$2.00B	$2.00B	$1.97B	$1.95B	$2.15B	$2.15B	$2.12B	$2.30B	$2.29B	$2.28B	$2.23B
Current liabilities	$473.70M	$447.44M	$483.05M	$476.61M	$456.59M	$594.39M	$607.53M	$595.68M	$961.52M	$407.12M	$416.36M	$367.79M
Long-term debt	$168.51M	$168.20M	$167.90M	$167.60M	$167.29M	$166.99M	$166.70M	$166.40M	$0	$571.22M	$570.44M	$569.66M
Total debt	$168.51M	$168.20M	$167.90M	$167.60M	$167.29M	$166.99M	$166.70M	$166.40M	$0	$571.22M	$570.44M	$569.66M
Total liabilities	$739.58M	$707.25M	$747.48M	$742.91M	$727.70M	$881.88M	$894.37M	$877.65M	$1.07B	$1.09B	$1.10B	$1.04B
Shareholders' equity	$1.32B	$1.29B	$1.26B	$1.23B	$1.22B	$1.26B	$1.26B	$1.24B	$1.23B	$1.20B	$1.19B	$1.19B

Cash flow

Cash flow
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Operating cash flow	$33.05M	$68.31M	$54.50M	$30.35M	$28.27M	$42.76M	$25.92M	$56.31M	$22.75M	$58.70M	$49.95M	$38.41M
Capital expenditures	$11.36M	$8.94M	$12.44M	$7.71M	$9.75M	$11.78M	$11.17M	$9.09M	$8.87M	$9.55M	$8.96M	$9.07M
Free cash flow	$21.69M	$59.37M	$42.06M	$22.64M	$18.51M	$30.97M	$14.75M	$47.23M	$13.89M	$49.15M	$41.00M	$29.34M
Investing cash flow	-$13.11M	-$12.53M	-$15.87M	-$14.42M	-$14.28M	-$15.92M	-$15.74M	-$13.57M	-$13.34M	-$13.55M	-$12.34M	-$12.37M
Financing cash flow	-$4.93M	-$23.38M	$2.39M	$9.10M	-$219.98M	-$11.47M	$4.04M	-$234.43M	$3.55M	-$16.63M	$11.93M	$13.13M
Share repurchases	$0	-	-	$0	$61.95M	-	-	$0	$0	-	-	$0
Stock-based compensation	$11.42M	$12.21M	$9.50M	$11.98M	$11.21M	$10.53M	$10.79M	$9.04M	$11.61M	$10.03M	$8.64M	$12.19M
Depreciation and amortization	$18.40M	$18.80M	$18.57M	$19.81M	$19.40M	$19.60M	$20.00M	$19.97M	$20.20M	$20.80M	$21.25M	$21.72M

Key ratios

Key ratios
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue growth, YoY	-0.9%	7.4%	14.9%	2.3%	10.0%	5.0%	9.6%	18.6%	-5.4%	-7.4%	-15.3%	-13.0%
Net income growth, YoY	102.2%	330.7%	-	-	-36.7%	51.0%	-	-	55.4%	8.2%	-	-
EPS growth, YoY	100.0%	333.3%	-	-	-36.8%	50.0%	-	-	58.3%	0.0%	-	-
Gross margin	44.8%	49.0%	45.3%	41.5%	43.3%	43.9%	41.1%	46.2%	43.3%	41.3%	37.6%	40.7%
Operating margin	4.9%	10.4%	5.4%	0.1%	2.7%	2.8%	-4.3%	4.0%	2.3%	1.2%	-8.9%	-9.0%
Net margin	3.6%	7.8%	3.7%	-0.6%	1.8%	1.9%	-2.6%	5.2%	3.1%	1.3%	-6.4%	-5.6%
Free cash flow margin	7.0%	19.0%	13.6%	7.2%	6.0%	10.7%	5.5%	15.4%	4.9%	17.8%	16.7%	11.3%
Current ratio	1.66	1.64	1.50	1.43	1.44	1.42	1.38	1.37	1.05	2.45	2.38	2.52
Debt to equity	0.13	0.13	0.13	0.14	0.14	0.13	0.13	0.13	0.00	0.47	0.48	0.48

Source: XBRL data Omnicell Inc. files with the SEC, latest filing dated Nov 4, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

OMCL peers

Company	Revenue	Growth	Net income	Net margin	Market cap
OMCL	$1.24B	+5.6%	$44.66M	3.6%	$1.72B
AAPLApple Inc.	$478.83B	+15.1%	$132.18B	27.6%	$4.98T
IBMInternational Business Machines Corporation	$69.87B	+6.8%	$11.17B	16.0%	$231.55B
DELLDell Technologies Inc.	$151.20B	+49.0%	$11.38B	7.5%	$208.88B
HPQHP Inc.	$59.16B	+8.1%	$2.45B	4.1%	$25.66B
SMCISuper Micro Computer Inc.	$53.99B	+156.5%	$3.66B	6.8%	$18.89B
OSSOne Stop Systems Inc.	$41.99M	-	$429.3K	1.0%	$107.8M
ZEPPZepp Health Corporation	$258.90M	+41.8%	-$40.07M	-15.5%	$33.0M

OMCL FAQ

9 questions

What is OMCL revenue?
Omnicell Inc. (OMCL) reported $1.24B of revenue for the twelve months ended Sep 30, 2026. That is up 5.6% from the year before. Revenue for fiscal 2025 was $1.18B.
Is OMCL profitable?
Yes. Omnicell Inc. earned $44.66M in net income for the twelve months ended Sep 30, 2026, a net margin of 3.6%.
How much cash and debt does OMCL have?
Omnicell Inc. reported $314.86M in cash and cash equivalents and $168.51M of debt on its most recent balance sheet in SEC filings.
How fast is OMCL revenue growing?
Omnicell Inc.'s revenue changed +6.5% in fiscal 2025, to $1.18B. Its compound annual growth rate was +5.8% over 5 years and +9.4% over 10 years.
What is OMCL gross margin?
Omnicell Inc.'s gross profit was $561.45M on $1.24B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 45.1%.
What is OMCL free cash flow?
Omnicell Inc. generated $145.77M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $186.22M less capital expenditures.
What is OMCL earnings per share?
Diluted earnings per share were $0.96 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did OMCL last report financial results?
The latest statements here come from Omnicell Inc.'s 10-Q filed on Nov 4, 2026, covering the period ended Sep 30, 2026.
Where does this OMCL financial data come from?
Quantisnow builds these statements from the structured XBRL data Omnicell Inc. files with the SEC. It is provided for information only and is not investment advice.